IP Library Patent Application 17663715
Patent Application
App. No. 17/663,715

LOW MOISTURE RAPIDLY DISINTEGRATING ORAL DISSOLVABLE FILM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/663,715
Abstract

The present invention provides for an oral dissolvable film that includes a rapidly dissolving binder, a film forming polymer, a moisture deterring polymer, and at least one of a first active ingredient and a second active ingredient. Also provided is a method of forming an oral dissolvable film and kits that include the oral dissolvable film. Also provided is a method of delivering one or more active ingredients to a subject that include orally administering the oral dissolvable film.

Claims (6)

1 . An oral dissolvable film comprising:

CBD (cannabidiol);

rapidly dissolving binder comprising polyvinyl alcohol (PVA) and polyvinyl alcohol (PVA)—polyethylene glycol (PEG) copolymer; and

film forming polymer comprising hydroxypropyl methyl cellulose (HPMC); wherein,

the oral dissolvable film has a moisture content of less than 8 wt. %, and

upon contact with the oral cavity, the oral dissolvable film disintegrates within 30 seconds.

Assignments (5)
LIEN Recorded Jan 28, 2025
From: CURE PHARMACEUTICAL, INC.
To: CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V.
Reel/Frame 070027/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2023
From: BERNARDO, JOSE; GIGI, VERED
To: CURE PHARMACEUTICAL HOLDING CORP.
Reel/Frame 064312/0374 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2023
From: CURE PHARMACEUTICAL HOLDING CORP.
To: CURE PHARMACEUTICAL CORPORATION
Reel/Frame 064312/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2023
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES, INC.
Reel/Frame 064312/0497 →
CHANGE OF NAME Recorded Jul 19, 2023
From: TF TECH VENTURES, INC.
To: CURE PHARMACEUTICAL, INC.
Reel/Frame 064343/0555 →